Altogether, these data support the notion that aberrant expression of miR-582-3p is likely to be another important contributor to downregulation of DKK3 and SFRP1, in addition to methylation—silencing of DKK3/SFRP1, in human NSCLC tissues. The gene discussed is DKK3; the disease is non-small cell lung carcinoma.